Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 1
2006 6
2007 8
2008 8
2009 4
2010 11
2011 8
2012 10
2013 10
2014 7
2015 6
2016 12
2017 6
2018 10
2019 12
2020 9
2021 21
2022 19
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Results by year

Filters applied: . Clear all
Page 1
Increasing Annual Cancer Incidence in Patients Age 20-49 Years: A Real-Data Study.
Ribelles N, Pascual J, Galvez-Carvajal L, Ruiz-Medina S, Garcia-Corbacho J, Benitez JC, Dominguez-Recio ME, Torres E, Oliva L, Zalabardo M, Rueda A, Alba E. Ribelles N, et al. Among authors: alba e. JCO Glob Oncol. 2024 Mar;10:e2300363. doi: 10.1200/GO.23.00363. JCO Glob Oncol. 2024. PMID: 38513186 Free PMC article.
NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancer.
Santana-Hernández S, Suarez-Olmos J, Servitja S, Berenguer-Molins P, Costa-Garcia M, Comerma L, Rea A, Perera-Bel J, Menendez S, Arpí O, Bermejo B, Martínez MT, Cejalvo JM, Comino-Méndez I, Pascual J, Alba E, López-Botet M, Rojo F, Rovira A, Albanell J, Muntasell A. Santana-Hernández S, et al. Among authors: alba e. J Exp Clin Cancer Res. 2024 Jan 3;43(1):10. doi: 10.1186/s13046-023-02918-4. J Exp Clin Cancer Res. 2024. PMID: 38167224 Free PMC article.
Comparative study of droplet-digital PCR and absolute Q digital PCR for ctDNA detection in early-stage breast cancer patients.
Sánchez-Martín V, López-López E, Reguero-Paredes D, Godoy-Ortiz A, Domínguez-Recio ME, Jiménez-Rodríguez B, Alba-Bernal A, Elena Quirós-Ortega M, Roldán-Díaz MD, Velasco-Suelto J, Linares-Valencia N, Garrido-Aranda A, Lavado-Valenzuela R, Álvarez M, Pascual J, Alba E, Comino-Méndez I. Sánchez-Martín V, et al. Among authors: alba e. Clin Chim Acta. 2024 Jan 1;552:117673. doi: 10.1016/j.cca.2023.117673. Epub 2023 Nov 23. Clin Chim Acta. 2024. PMID: 38007055 Free article.
Explainable clinical coding with in-domain adapted transformers.
López-García G, Jerez JM, Ribelles N, Alba E, Veredas FJ. López-García G, et al. Among authors: alba e. J Biomed Inform. 2023 Mar;139:104323. doi: 10.1016/j.jbi.2023.104323. Epub 2023 Feb 20. J Biomed Inform. 2023. PMID: 36813154 Free article.
Development of a Novel NGS Methodology for Ultrasensitive Circulating Tumor DNA Detection as a Tool for Early-Stage Breast Cancer Diagnosis.
Jiménez-Rodríguez B, Alba-Bernal A, López-López E, Quirós-Ortega ME, Carbajosa G, Garrido-Aranda A, Álvarez M, Godoy-Ortiz A, Queipo-Ortuño MI, Vicioso L, Díaz-Córdoba G, Roldán-Díaz MD, Velasco-Suelto J, Hernando C, Bermejo B, Julve-Parreño A, Lluch A, Pascual J, Comino-Méndez I, Alba E. Jiménez-Rodríguez B, et al. Among authors: alba e. Int J Mol Sci. 2022 Dec 21;24(1):146. doi: 10.3390/ijms24010146. Int J Mol Sci. 2022. PMID: 36613590 Free PMC article.
Development of in vitro and in vivo tools to evaluate the antiangiogenic potential of melatonin to neutralize the angiogenic effects of VEGF and breast cancer cells: CAM assay and 3D endothelial cell spheroids.
Laborda-Illanes A, Sánchez-Alcoholado L, Castellano-Castillo D, Boutriq S, Plaza-Andrades I, Aranega-Martín L, Peralta-Linero J, Alba E, González-González A, Queipo-Ortuño MI. Laborda-Illanes A, et al. Among authors: alba e. Biomed Pharmacother. 2023 Jan;157:114041. doi: 10.1016/j.biopha.2022.114041. Epub 2022 Nov 21. Biomed Pharmacother. 2023. PMID: 36423543 Free article.
Dual neoadjuvant blockade plus chemotherapy versus monotherapy for the treatment of women with non-metastatic HER2-positive breast cancer: a systematic review and meta-analysis.
Vazquez JC, Antolin S, Ruiz-Borrego M, Servitja S, Alba E, Barnadas A, Lluch A, Martin M, Rodriguez-Lescure A, Sola I, Bonfill X, Urrutia G, Sanchez-Rovira P. Vazquez JC, et al. Among authors: alba e. Clin Transl Oncol. 2023 Apr;25(4):941-958. doi: 10.1007/s12094-022-02998-2. Epub 2022 Nov 22. Clin Transl Oncol. 2023. PMID: 36417083 Review.
Association of Circular RNA and Long Non-Coding RNA Dysregulation with the Clinical Response to Immune Checkpoint Blockade in Cutaneous Metastatic Melanoma.
Oliver J, Onieva JL, Garrido-Barros M, Berciano-Guerrero MÁ, Sánchez-Muñoz A, José Lozano M, Farngren A, Álvarez M, Martínez-Gálvez B, Pérez-Ruiz E, Alba E, Cobo M, Rueda-Domínguez A, Barragán I. Oliver J, et al. Among authors: alba e. Biomedicines. 2022 Sep 27;10(10):2419. doi: 10.3390/biomedicines10102419. Biomedicines. 2022. PMID: 36289681 Free PMC article.
The value of sentinel lymph-node biopsy in women with node-positive breast cancer at diagnosis and node-negative tumour after neoadjuvant therapy: a systematic review.
Vázquez JC, Piñero A, de Castro FJ, Lluch A, Martín M, Barnadas A, Alba E, Rodríguez-Lescure Á, Rojo F, Giménez J, Solá I, Quintana MJ, Bonfill X, Urrutia G, Sánchez-Rovira P. Vázquez JC, et al. Among authors: alba e. Clin Transl Oncol. 2023 Feb;25(2):417-428. doi: 10.1007/s12094-022-02953-1. Epub 2022 Sep 25. Clin Transl Oncol. 2023. PMID: 36153763 Review.
154 results